30134-53-3

Basic information

• Product Name: Butanoic acid, 4-cyano-2-[[(phenylmethoxy)carbonyl]amino]-, methyl ester, (2S)-
• CAS NO: 30134-53-3
• Molecular Formula: C14H16N2O4
• Molecular Weight: 276.292
• Mol File: 30134-53-3.mol
• Article Data: 10

Chemical Properties

• CAS DataBase Reference: Butanoic acid, 4-cyano-2-[[(phenylmethoxy)carbonyl]amino]-, methyl ester, (2S)-(CAS DataBase Reference)
• NIST Chemistry Reference: Butanoic acid, 4-cyano-2-[[(phenylmethoxy)carbonyl]amino]-, methyl ester, (2S)-(30134-53-3)
• EPA Substance Registry System: Butanoic acid, 4-cyano-2-[[(phenylmethoxy)carbonyl]amino]-, methyl ester, (2S)-(30134-53-3)

Safety Data

• Hazardous Substances Data: 30134-53-3(Hazardous Substances Data)

Upstream product

• 15159-67-8 (2S)-2-benzyloxycarbonylamino-4-bromo-butyric acid methyl ester 
• 151-50-8 potassium cyanide 
• 143-33-9 sodium cyanide 
• 98-59-9 p-toluenesulfonyl chloride 
• 127105-49-1 methyl (2S)-2-amino-4-(tetrazol-5-yl)-butyrate 
• 773837-37-9 sodium cyanide 
• 314728-04-6 (S)-2-benzyloxycarbonylamino-4-hydroxybutyric acid methyl ester 
• 2650-67-1 (R)-2-Benzyloxycarbonylamino-4-carbamoyl-butyric acid methyl ester 
• 13907-82-9 N²-benzyloxycarbonyl-L-glutamine methyl ester 

Downstream Products

• 15231-21-7 (S)-2-((phenylmethoxycarbonyl)amino)-4-cyanobutanoic acid 
• 30134-55-5 ((S)-2-Benzyloxycarbonylamino-4-cyano-butyrylamino)-acetic acid ethyl ester 
• 30134-54-4 (S)-2-Benzyloxycarbonylamino-4-cyano-butyric acid 2,4,5-trichloro-phenyl ester 
• 65882-90-8 methyl (2S)-2-(benzyloxycarbonylamino)-4-(tetrazol-5-yl)butyrate 
• 165754-55-2 HUN-7293 

Relevant articles and documents

Bis-morpholinophosphorylchloride, a novel reagent for the conversion of primary amides into nitriles

Bis-morpholinophosphorylchloride (Bmpc), in the presence of a base, is an efficient dehydrating agent for both aromatic and aliphatic primary amides, and gives corresponding nitriles under mild conditions in god yields and purity. During the reaction the enantiomeric integrity remains intact.

MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS

Provided herein are antibacterial compounds, wherein the compounds in some embodiments have broad spectrum bioactivity. In various embodiments, the compounds act by inhibition of bacterial type 1 signal peptidase (SpsB), an essential protein in bacteria. Pharmaceutical compositions and methods for treatment using the compounds described herein are also provided.

Quinazoline thymidylate synthase inhibitors

The invention relates to quinazoline derivatives or pharceutically-acceptable salts thereof, which possess anti-tumor activity; to processes for their manufacture; and to pharmaceutical compositions containing them. The invention provides a quinazoline of the formula: STR1 wherein R1 is (1-4C)alkyl; the quinazoline ring may optionally bear one or two further substituents selected from halogeno, (1-4C)alkyl and (1-4C)alkoxy; R2 is hydrogen or (1-4C)alkyl; R3 includes hydrogen and (1-4C)alkyl; and Ar is optionally substituted phenylene or heterocyclene; or a pharmaceutically-acceptable salt or ester thereof.